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Brassinosteroids (BRs) regulate plant development
through a signal transduction pathway involving the
BRI1 and BAK1 transmembrane receptor kinases.
The detailed molecular mechanisms of phosphoryla-
tion, kinase activation, and oligomerization of the
BRI1/BAK1 complex in response to BRs are uncer-
tain. We demonstrate that BR-dependent activation
of BRI1 precedes association with BAK1 in planta,
and that BRI1 positively regulates BAK1 phosphory-
lation levels in vivo. BRI1 transphosphorylates BAK1
in vitro on specific kinase-domain residues critical for
BAK1 function.BAK1also transphosphorylatesBRI1,
thereby quantitatively increasing BRI1 kinase activity
toward a specific substrate.We propose a sequential
transphosphorylation model in which BRI1 controls
signaling specificity by direct BR binding followed
by substrate phosphorylation. The coreceptor BAK1
is then activated by BRI1-dependent transphosphor-
ylation and subsequently enhances signaling output
through reciprocal BRI1 transphosphorylation. This
model suggests both conservation and distinct dif-
ferences between the molecular mechanisms regu-
lating phosphorylation-dependent kinase activation
in plant and animal receptor kinases.
INTRODUCTION
Brassinolide (BL) is themost biologically activemember of a fam-
ily of plant steroid hormones termed brassinosteroids (BRs),
which are essential regulators ofmultiple aspects of plant growth
and development (Clouse and Sasse, 1998). BL initiates a cas-
cade of cellular events by binding to the extracellular domain
of the BRASSINOSTEROID-INSENSTIVE 1 (BRI1) receptor
kinase, which leads to phosphorylation and activation of the
BRI1 cytoplasmic kinase domain (KD) and transduction of the
signal via an intracellular kinase to the nucleus, where several220 Developmental Cell 15, 220–235, August 12, 2008 ª2008 Elsevnovel BR-responsive transcription factors alter the expression
of genes promoting cell elongation, division, and differentiation
(Li and Nam, 2002; He et al., 2005; Kinoshita et al., 2005; Yin
et al., 2005; Vert and Chory, 2006). Mutational analysis in Arabi-
dopsis thaliana and several crop plants has shown that lesions in
either the extracellular or cytoplasmic domains (CDs) of BRI1
can lead to severe developmental defects, including extreme
dwarfism, altered leaf and vascular morphology, delayed senes-
cence and flowering, and male infertility (Clouse et al., 1996; Li
and Chory, 1997; Yamamuro et al., 2000; Montoya et al., 2002).
These genetic data confirm the importance of BRI1-mediated
BR signaling in normal plant development and have prompted
intensive research on BRI1 function. However, the precise
biochemical mechanism by which BRI1 activates this pathway
in response to BL binding remains unclear (Gendron and Wang,
2007).
BRI1 belongs to the very large family of leucine-rich repeat re-
ceptor-like kinases (LRR RLKs) found in plants that includes over
220 members in Arabidopsis and nearly 400 in rice (Shiu et al.,
2004). LRR RLKs have an organization of functional domains
similar to that of mammalian receptor tyrosine kinases (RTKs)
and transforming growth factor-b (TGF-b) serine/threonine
receptor kinases, including an extracellular domain potentially
involved in ligand binding and receptor oligomerization, a sin-
gle-pass transmembrane sequence, and a CD consisting of
a catalytic KD and flanking regulatory sequences—the juxta-
membrane (JM) region and the carboxy-terminal (CT) domain.
The well-established paradigm for mammalian receptor kinase
action begins with ligand-induced oligomerization, which pro-
motes CD activation by autophosphorylation, followed by the
generation of phosphorylation-dependent interaction motifs for
binding specific downstream substrates (Massague, 1998;
Schlessinger, 2002; Rahimi and Leof, 2007). Receptor kinase
phosphorylation occurs on multiple sites in the KD, JM, and CT
regions (Huse and Kuriyan, 2002). Phosphorylation of 1–3 resi-
dues in the conserved activation loop of kinase subdomains
VII/VIII is a common mechanism of general kinase activation
and, in some cases, also affects binding of kinase substrates
(Adams, 2003). Phosphorylation of JM and CT regions, which
show more sequence diversity among receptor kinases than
the activation loop, generates docking sites for specific kinaseier Inc.
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activation by a variety of mechanisms (Pawson, 2002).
BRI1 appears to share some of the same general mechanistic
features of kinase activation and function seen in mammalian
receptor kinases. The extracellular domain of BRI1 consists of
25 tandem LRRs with a 70 amino acid island imbedded between
LRR 21 and 22. The island domain in conjunction with LRR 22 di-
rectly binds BL, defining a new steroid binding motif (Kinoshita
et al., 2005). We previously identified at least 11 sites of in vivo
phosphorylation in the JM, KD, and CT domains of BRI1 by
immunoprecipitation from BL-treated Arabidopsis seedlings
followed by liquid chromatography-tandem mass spectrometry
(LC/MS/MS) analysis and also found that BRI1 phosphorylation
in planta on many of these residues was BL-dependent (Wang
et al., 2005b). Moreover, BRI1 KD autophosphorylation sites
identified in vitro (Oh et al., 2000) were highly predictive of
in vivo phosphorylation. Functional characterization of each
identified site by biochemical and genetic analyses showed
that the highly conserved activation-loop residues, S1044 and
T1049, were critical for kinase function in vitro and proper BR
signaling in planta, while multiple JM and CT residues were
required for optimal substrate phosphorylation by the BRI1 KD
(Wang et al., 2005b). An autoinhibitory role of the CT region of
BRI1 has also been reported (Wang et al., 2005a).
BRI1 can exist in plant membranes as a ligand-independent
homodimer that is stabilized and activated by BL binding (Russi-
nova et al., 2004;Wang et al., 2005a; Hink et al., 2008). However,
full expression of BR signaling requires the association of
BRI1 with other LRR RLKs. The SOMATIC EMBRYOGENESIS
RECEPTOR KINASE (SERK) subfamily of LRR RLKs contains
five closely related members (Hecht et al., 2001) that have small
extracellular domains consisting of only five LRRs that lack the
island domain of BRI1 and thus cannot bind BL directly.
SERK3, also known as BRI1-ASSOCIATED RECEPTOR KINASE
1 (BAK1), interacts both in vitro and in vivo with BRI1 (Li et al.,
2002; Nam and Li, 2002; Russinova et al., 2004), and we showed
that this association was promoted by BR, as was in vivo phos-
phorylation of both LRR RLKs (Wang et al., 2005b). Moreover,
overexpression of a K317E kinase-inactive mutant form of
BAK1 in bri1-5 (a weak allele of bri1) led to a severe dwarf
phenotype resemblingbri1nullmutant alleles, suggesting adom-
inant-negative effect arising from the disruption of a complex
between BRI1 and BAK1 (Li et al., 2002). The bak1-4 null allele
shows only partial BR insensitivity and a weak bri1-like pheno-
type, indicating possible functional redundancy with other
SERK-family members. SERK4, alternatively named BAK1-
LIKE (BKK1), also interacts with BRI1 in vivo in a BL-dependent
manner, and overexpression of kinase-inactive BKK1 in bri1-5
leads to a dominant-negative effect similar to that observed
with BAK1 (He et al., 2007). Thus, BAK1 and BKK1 functionally
overlap in BR signaling. Surprisingly, the bak1 bkk1 double
mutant does not exhibit a strong bri1-like dwarf phenotype
with altered leaf morphology, but, instead, it shows a novel seed-
ling-lethal dwarfism. Biochemical and genetic analyses support
a positive regulatory role for both BAK1 and BKK1 in BR signal-
ing and a negative role for these two LRR RLKs in a currently
undefined BR-independent cell-death pathway (He et al., 2007;
Kemmerling et al., 2007). The seedling lethality of the bak1
bkk1 double mutant is attributed to derepression of this cell-Develodeath pathway. Moreover, BAK1 heterodimerizes with another
LRR RLK known to bind a peptide derivative of bacterial flagellin,
FLAGELLIN-SENSITIVE2 (FLS2), and promotes its function in
plant defense responses (Chinchilla et al., 2007; Heese et al.,
2007). Thus, BAK1 functions in independent pathways by
enhancing the signaling output of distinct LRR RLKs that bind
different ligands. Finally, SERK1, known to be involved in em-
bryogenesis, also physically interacts with BRI1 and enhances
BR signaling (Karlova et al., 2006), suggesting that SERKs, in
general, are coreceptors that regulate multiple independent
pathways by heterodimerization or oligomerization with different
LRR RLKs.
Although a great deal has been discovered regarding BR sig-
naling during the past decade, a major gap in our understanding
lies in the early molecular events that regulate BL-dependent
BRI1/BAK1 asssociation and phosphorylation. In this study, we
identify specific sites of in vivo phosphorylation of BAK1 and pro-
vide genetic and biochemical evidence for a sequential trans-
phosphorylation mechanism for BRI1 and BAK1 activation that
shares some similarities with, but also unique differences from,
mammalian RTK and TGF-b models. Our data are consistent
with a model in which BRI1 kinase function is initially activated
to a basal level by BL binding to BRI1 in the absence of BAK1.
The activated BRI1 then associates with BAK1 and transphos-
phorylates it on KD residues. BRI1-activated BAK1 subsequently
transphosphorylates specific JM and CT residues in BRI1,
thereby increasing BRI1 kinase activity and substrate phosphor-
ylation, leading to enhanced BR signaling and increased plant
growth.
RESULTS
The Role of Kinase Activity in the BRI1/BAK1
Association
To elucidate the detailed mechanisms of receptor kinase activa-
tion in response to BR, we examined the effect of kinase activity
on the association and phosphorylation of epitope-tagged BRI1
and BAK1 in various genetic backgrounds. We previously used
double transgenic Arabidopsis lines expressing both BRI1-Flag
and BAK1-GFP in a wild-type background to show that BL
strongly promoted coimmunoprecipitation of BRI1-Flag and
BAK1-GFP and induced phosphorylation on Thr residues in
both (Wang et al., 2005b). Here (Figure 1A), we demonstrate
that inactivation of the BRI1-Flag KD by a K911E substitution
(Oh et al., 2000) abolishes the BL-dependent increase in the
association of BRI1-Flag with BAK1-GFP, suggesting that an
active BRI1 kinase strongly enhances oligomerization with
BAK1 in vivo. In contrast, when BAK1-GFP kinase activity was
eliminated by a K317E substitution (Li et al., 2002), the mutated
LRR RLK was still able to associate with wild-type BRI1-Flag
in a BL-dependent manner (Figure 1A), although at slightly
reduced levels. The extent of BRI1-Flag phosphorylation in
planta was clearly affected by the level of BAK1 kinase activity.
Overexpression of BAK1-GFP in double transgenic lines in-
creased BRI1-Flag phosphorylation compared to single BRI1-
Flag transgenic lines, in which only endogenous BAK1 activity
was present. In contrast, overexpression of kinase-inactive
BAK1(K317E)-GFP decreased BRI1-Flag phosphorylation below
the level of the wild-type BAK1 background, most likely duepmental Cell 15, 220–235, August 12, 2008 ª2008 Elsevier Inc. 221
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Molecular Mechanisms of the BRI1/BAK1 InteractionFigure 1. BL-Dependent Association of BRI1 and BAK1 Leads to Enhanced Kinase Activity and Increased BR Signaling
(A) T3 homozygous transgenic Arabidopsis plants expressing both BRI1-Flag and BAK1-GFP were grown with the BR biosynthesis inhibitor Brz (2.0 mM added
after 6 days of initial growth) and were then treated with BL or solvent for 90 min at day 11. Total membrane protein was immunoprecipitated and subjected to
immunoblot analysis as indicated. Kinase-inactive constructs (mBRI1 = K911E and mBAK1 = K317E) were used to show that BRI1, but not BAK1, kinase activity
is essential for BR-dependent in vivo association of the pair, as monitored by coimmunoprecipitation.
(B) BAK1-GFP in vivo phosphorylation is reduced in a bri1-1 null mutant background and is enhanced in a BRI1-Flag-overexpressing line.
(C) BL-dependent in vivo phosphorylation of BRI1-Flag still occurs in single bak1-4 and bkk1-1 null mutants and in the double knockout. Sypro Ruby stain shows
total membrane protein loading for the a-Flag microsomal blot. BRI1-Flag levels were reduced in the bak1-4 bkk1-1 background and were eliminated in the
presence of Brz without BL. BRI1-Flag protein levels were normalized after immunoprecipitation for the a-pThr blot, except for bak1-4 bkk1-1 (+Brz/BL), which
contained no detectable BRI-Flag.
(D) Phosphorylation of the peptide substrate BR13 (GRJKKIASVEJJKK, J = norLeu) by Flag-BRI1-CD (1.0 mM) is increased over three-fold by the addition of
GST-BAK1-CD (1.0 mM) and is dependent on an active BAK1 kinase. Error bars are standard error of the mean (SEM); n = 3.
(E) Hypocotyl length in 14-day-old light-grown Arabidopsis shows a dependence on BRI1 and BAK1 kinase activities and levels that correlate with (A–C) in vivo
and (D) in vitro assays. Error bars are SEM; n = 50. All transgenic plants are T3 homozygous lines; transgenic protein levels were verified by immunoblot analysis
(data not shown). +/+, wild-type homozyogous; +/, wild-type heterozygous; /, homozygous mutant; 35S, CaMV strong constitutive promoter. Transgenic
constructs are the same as in (A).222 Developmental Cell 15, 220–235, August 12, 2008 ª2008 Elsevier Inc.
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BAK1(K317E)-GFP replacing wild-type endogenous BAK1 in a
complex with BRI1-Flag. A similar dependence of phosphoryla-
tion levels of BAK1-GFP on the level of BRI1 kinase activity was
also observed (Figure 1A).
The low baseline level of BAK1-GFP phosphorylation ob-
served in mBRI1-Flag transgenics (Figure 1A) is likely due to
the association of BAK1-GFP with endogenous BRI1. Therefore,
to further investigate the role of BRI1 kinase activity on BAK1
phosphorylation levels in vivo, BAK1-GFP was expressed in a
bri1-1 null mutant that completely lacks BRI1 activity due to a
point mutation in the KD. Figure 1B shows that BAK1-GFP
in vivo phosphorylation is enhanced in a BRI1-Flag-overexpress-
ing line and is reduced to an almost undetectable level in the
bri1-1mutant background. Thus, BRI1 kinase activity is essential
for BL-dependent BAK1 phosphorylation in vivo. The reciprocal
experiment evaluating the role of BAK1 kinase activity on BRI1
phosphorylation levels in vivo is complicated by the functional
redundancy of BAK1 and BKK1. As seen in Figure 1C, when
monitoring equal amounts of immunoprecipitated protein, ex-
pression of BRI1-Flag in the null mutant allele bak1-4 results in
substantially reduced BL-dependent phosphorylation compared
to expression in wild-type Col-0, which correlates well with the
previously reported partial BR-insensitive phenotype of bak1-4
(He et al., 2007). However, no such reduction in BRI1-Flag phos-
phorylation is seen after expression in the bkk1-1 null mutant,
which, again, correlates with the lack of observable develop-
mental defects reported for the bkk1-1 single mutant (He et al.,
2007). Also, as previously reported, bak1-4 bkk1-1 double mu-
tants show an extreme phenotype, including seedling lethality,
that is distinct from the bri1-1 null allele (He et al., 2007). There-
fore, it is significant that expression of BRI1-Flag in the bak1-4
bkk1-1 double mutant results in BL-dependent phosphorylation
of BRI1-Flag to at least the level of the bak1-4 single mutant,
indicating that BRI1 can recognize and respond to BL in the
complete absence of both BAK1 and BKK1, although at reduced
levels of phosphorylation when compared to wild-type. Interest-
ingly, BRI1-Flag was unstable in the bak1-4 bkk1-1 background
when endogenous BL was reduced by treatment with the
BR biosynthesis inhibitor brassinazole (Brz), which was not
seen in either single mutant or in the double mutant in the
absence of Brz.
Transphosphorylation of BRI1 by BAK1 Enhances BRI1
Kinase Activity in Substrate Phosphorylation Assays
To investigate in greater depth the biochemical mechanisms by
which association of BRI1 and BAK1 leads to increased kinase
activity of either receptor kinase, the complete CD of BAK1 fused
to an N-terminal glutathione S-transferase (GST) sequence, was
incubated with the entire CD of BRI1 fused to an N-terminal Flag
epitope tag. Flag-BRI1-CD activity was monitored by phosphor-
ylation levels of a synthetic peptide (BR13) containing the previ-
ously determined consensus sequence for optimum BRI1 sub-
strate phosphorylation (Oh et al., 2000). GST-BAK1-CD alone
did not phosphorylate BR13 significantly when compared to
Flag-BRI1-CD alone. However, a mixture of equal protein
amounts of GST-BAK1-CD and Flag-BRI1-CD resulted in over
three times the level of BR13 phosphorylation with respect to
Flag-BRI1-CD alone (Figure 1D). This stimulatory effect wasDevelopdependent on BAK1 kinase activity since substitution of ki-
nase-inactive GST-BAK1(K317E)-CD for GST-BAK1-CD in the
mixture resulted in BR13 phosphorylation levels similar to those
with Flag-BRI1-CD alone.
The positive regulatory interaction between BRI1 and BAK1
observed both in vivo and in vitro was also examined at the
whole-plant level by using hypocotyl length as a read-out for
BR signaling in a physiological response known to be strongly
promoted by BR (Li et al., 2002; Wang et al., 2005a). The critical
role of BRI1 in hypocotyl elongation is well documented (Clouse
and Sasse, 1998) and is demonstrated in Figure 1E, in which
a bri1-1 null allele shows hypocotyl lengths less than one-sev-
enth that of wild-type Arabidopsis. In contrast, bak1-4 bkk1-1
double mutants have hypocotyls that are shorter than wild-
type but substantially longer than bri1-1 mutants, suggesting
that BRI1 activity is more critical for hypocotyl elongation than
BAK1 and BKK1. This is confirmed by the observation that over-
expression of BRI1-Flag in the bak1-4 bkk1-1 double mutant
rescues hypocotyl length to wild-type length, whereas overex-
pression of BAK1-GFP in the bri1-1 null mutant has no effect
on hypocotyl elongation (Figure 1E). This is consistent with the
observation in Figures 1B and 1C that BRI1 continues to function
in a BL-dependent manner in the bak1-4 bkk1-1 double mutant
background, whereas BL-dependent BAK1 phosphorylation is
lost in the bri1-1 null mutant. However, BAK1 does stimulate
BRI1-mediated hypocotyl elongation, since even a single active
copy of BAK1 in the BRI1-Flag overexpression line leads to
increased hypocotyl lengths, as does overexpression of BAK1-
GFP in a genetic background containing at least one active
copy of BRI1 (Figure 1E). This is consistent with the stimulation
of BRI1 kinase activity by BAK1 seen in vitro (Figure 1D) and
the enhanced phosphorylation of BRI1 in vivo promoted by over-
expression of BAK1 (Figure 1A). Overexpression of kinase-inac-
tive 35S-mBAK1-GFP in the bak1-4 bkk1-1 double mutant,
which has an active BRI1 allele, does not increase hypocotyl
length when compared to the untransformed double mutant,
confirming that BAK1 kinase activity is required for stimulation
of BRI1 function (Figure 1E).
Transphosphorylation within an oligomeric complex is one
mechanism by which BRI1 and BAK1 could affect the activity
of the corresponding receptor kinase. By pairing active BRI1
with kinase-inactive BAK1, and vice versa, Figure 2A clearly
shows that transphosphorylation between BRI1 and BAK1 CDs
occurs in vitro, in both directions. The importance of transphos-
phorylation of BRI1 by BAK1 in enhancing BRI1 activity in the
BR13 peptide assay was further demonstrated by preincubating
Flag-BRI1-CD bound to agarose beads with free GST-BAK1-CD
in the presence or absence of ATP, followed by washing away
soluble components before the BR13 peptide assay. Flag-
BRI1-CD bound to beads gave the same three-fold increase in
BR13 phosphorylation when GST-BAK1-CD was included in
the peptide assay (Figure 2B), as was observed for soluble
Flag-BRI1-CD (Figure 1D). However, preincubation of Flag-
BRI1-CD beads with soluble GST-BAK1 and ATP resulted in
a nearly six-fold increase in BRI1 activity, even when BAK1
was not added to the subsequent peptide assay. When ATP
was removed from the preincubation solution, the resulting acti-
vation was dramatically reduced, confirming the importance of
BAK1 phosphorylation of BRI1 in the activation mechanism.mental Cell 15, 220–235, August 12, 2008 ª2008 Elsevier Inc. 223
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Molecular Mechanisms of the BRI1/BAK1 InteractionFigure 2. BAK1-CD Increases BRI1-CD Kinase Activity by Transphosphorylation
(A) Incubation of equal protein amounts (1.0 mM) of active and inactive (mBRI1 = K911E and mBAK1 = K317E) recombinant BRI1 and BAK1cytoplasmic domains
with [g-32P]ATP shows that Flag-BRI1-CD and GST-BAK1-CD can both autophosphorylate and transphosphorylate each other. Sypro Ruby staining (bottom
panel) shows protein loading for the autoradiograph (top panel).
(B) Preincubating Flag-BRI1 bound to agarose beads with soluble GST-BAK1 and ATP greatly enhances subsequent phosphorylation of the BR13 peptide by
Flag-BRI1, even when GST-BAK1 is not included in the peptide assay, suggesting that BRI1 phosphorylation by BAK1 increases BRI1 activity toward specific
substrates.
(C) GST-BAK1-CD by itself cannot phosphorylate BR13 directly under any condition tested, indicating that BAK1 enhances BR13 phosphorylation by activating
BRI1.
(D) Protein levels and kinase activities for each of the reactions in (B) (B2–B7) and (C) (C2–C7) are shown.
For (B) and (C), error bars are SEM; n = 3.Interestingly, preincubation of Flag-BRI1-CDwith ATP alone also
resulted in higher activities in the subsequent peptide assay than
in controls without preincubation, suggesting that autophos-
phorylation also primed BRI1 for higher activity with respect to
BR13 substrate phosphorylation, although not to the same ex-
tent as ATP + BAK1. Thus, the phosphorylation status of BRI1
at the time substrate is presented is important for optimal peptide
phosphorylation, and BAK1 is clearly able to transphosphorylate
BRI1, leading to increased activity of BRI1 toward specific
substrates. The specificity of BRI1 for the BR13 peptide was
also confirmed in this assay, since no preincubation treatment
of GST-BAK1-CD resulted in significant BR13 phosphorylation224 Developmental Cell 15, 220–235, August 12, 2008 ª2008 Elseviunless Flag-BRI1-CD was included in the peptide assay
(Figure 2C).
BAK1 Is Phosphorylated on Mulitple Kinase Domain
Residues In Vivo and In Vitro
To refine the biochemical mechanisms by which BRI1 and BAK
interact and activate each other, identification of specific sites
of phosphorylation in each LRRRLK is necessary. Using a similar
experimental approach to that used previously for BRI1 (Wang
et al., 2005b), we identified five sites of in vivo phosphorylation
in BAK1-GFP immunoprecipitated from BL-treated tissue
(Table 1). In contrast to BRI1, which showed phosphorylationer Inc.
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Peptidea Calc.b [M+H]+ Measured [M+H]+ Chg. SEQUEST Xcorrc DCn
d Mascot Scoree Identified Site
In Vivo Phosphorylation Sites of Immunoprecipitated BAK1-GFP (Ion Trap)f
280-R.ELQVASDNFpSNKNILGR.G-298 1986.1 1984.9 2 3.430 0.216 62 S290
307-R.LADGpTLVAVK.R-318 1067.2 1066.2 1 2.342 0.133 25g T312
439-K.LM*DYKDpTHVTTAVR.G-454 1746.9 1747.3 3 3.567 0.189 48 T446
439-K.LM*DYKDTHVpTTAVR.G-454 1746.9 1745.7 2 3.063 0.103 48 T449
439-K.LMDYKDpTHVpTTAVR.G-454 1810.8 1810.1 2 3.440 0.132 n.d.h T446, T449
453-R.GpTIGHIAPEYLSTGK.S-469 1624.7 1625.4 3 3.295 0.305 47 T455
In Vitro Phosphorylation Sites of GST-BAK1-CD (Ion Trap)
280-R.ELQVApSDNFSNK.N-293 1432.4 1433.0 2 3.179 0.175 43 S286
280-R.ELQVASDNFpSNKNILGR.G-298 1986.1 1986.2 2 4.188 0.130 68 S290
307-R.LADGpTLVAVKR.L-319 1223.3 1222.8 2 3.462 0.610 71 T312
439-K.LM*DYKDpTHVTTAVR.G-454 1746.8 1746.2 2 4.134 0.139 47 T446
439-K.LMDYKDpTHVpTTAVR.G-454 1810.8 1810.2 2 4.927 0.118 42 T446, T449
439-K.LM*DYKDTHVTpTAVR.G-454 1746.8 1747.1 3 3.674 0.110 44 T450
453-R.GpTIGHIAPEYLSTGK.S-469 1624.7 1623.9 3 3.754 0.321 68 T455
In Vitro Phosphorylation Sites of GST-BAK1-CD (Q-ToF)
280-R.ELQVApSDNFSNK.N-293 1431.616 1431.623 2 n/ai n/a 26g S286
280-R.ELQVASDNFpSNKNILGR.G-298 1984.949 1984.927 3 n/a n/a 31g S290
307-R.LADGpTLVAVKR.L-319 1222.656 1222.655 2 n/a n/a 44 T312
439-K.LM*DYKDpTHVTTAVR.G-454 1745.793 1745.770 3 n/a n/a 23g T446
439-K.LM*DYKDTHVpTTAVR.G-454 1745.793 1745.798 2 n/a n/a 28g T449
444-K.DTHVTpTAVR.G-454 1079.489 1079.491 2 n/a n/a 40 T450
453-R.GpTIGHIAPEYLSTGK.S-469 1623.778 1623.782 2 n/a n/a 64 T455
In Vitro Transphosphorylation of GST-mbak1-CD 3 Flag-BRI1-CD (Ion Trap)
280-R.ELQVASDNFpSNKNILGR.G-298 1986.1 1986.4 2 3.871 0.298 62 S290
307-R.LADGpTLVAVKR.L-319 1223.3 1224.1 2 2.405 0.262 63 T312
439-K.LM*DYKDpTHVTTAVR.G-454 1746.9 1745.8 2 3.048 0.134 51 T446
439-K.LM*DYKDTHVpTTAVR.G-454 1746.8 1746.4 2 4.755 0.043 58 T449
439-K.LMDYKDTHVTpTAVR.G-454 1730.8 1729.9 2 2.284 0.148 50 T450
453-R.GpTIGHIAPEYLSTGK.S-469 1624.7 1624.8 2 2.964 0.484 71 T455
In Vitro Transphosphorylation of GST-mbak1-CD 3 Flag-BRI1-CD (Q-ToF)
439-K.LM*DYKDpTHVTTAVR.G-454 1745.793 1745.779 3 n/a n/a 27g T446
439-K.LMDYKDTHVpTTAVR.G-454 1729.798 1729.793 3 n/a n/a 51 T449
In Vitro Transphosphorylation of Flag-mbri1-CD 3 GST-BAK1-CD (Ion Trap)
824-K.EAELEMYAEGHGNpSGDR.T-842 1945.9 1945.9 2 1.793 0.254 46 S838
841-R.TANNpTNWKLTGVK.E-855 1527.6 1526.6 2 2.384 0.098 36g T846
854-K.EALpSINLAAFEKPLR.K-870 1752.9 1752.2 2 1.778 0.277 37g S858
1156-K.EIQAGSGIDpSQSTIR.S-1171 1642.6 1642.3 2 3.805 0.112 67 S1166
1171-R.SIEDGGFSpTIEMVDMSIK.E-1190 2040.2 2038.5 2 3.69 0.118 68 T1180
In Vitro Transphosphorylation of Flag-mbri1-CD 3 GST-BAK1-CD (Q-ToF)
841-R.TANNpTNWK.L-850 1028.420 1028.428 2 n/a n/a 8g T846
a The amino acid residues appearing before and after the periods correspond to the residues preceding and following, respectively, the peptide in the
protein sequence. Methionine sulfoxide is denoted as M*, and phosphoseryl and phosphothreonyl residues are denoted as pS and pT, respectively.
b The average mass for ion trap and the monoisotopic mass for Q-ToF.
c The SEQUEST crosscorrelation score (Xcorr) of the peptide is based on thematch of the obtained product ion spectrum to the theoretical product ion
spectrum for the corresponding peptide contained in the database.
dDifference of crosscorrelation scores between the top two Xcorrs for a given product ion spectrum.
eMascot scores are above the peptide identity threshold (p < 0.05), except where indicated.
f Spectra for all in vivo sites are provided in the Supplemental Data.
g TheseMascot scores were below the threshold level, but manual inspection of the spectrum confirmed phosphorylation at the residue indicated. See
the Supplemental Data for spectra.
h The Mascot search did not score this peptide.
i Q-ToF data were analyzed by Mascot only.Developmental Cell 15, 220–235, August 12, 2008 ª2008 Elsevier Inc. 225
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Molecular Mechanisms of the BRI1/BAK1 Interactionthroughout the CD, all of the identified BAK1 phosphorylation
sites were within the KD, including S290 in subdomain I; T312
in subdomain II; and three residues, T446, T449, and T455, in
the activation loop of subdomains VII/VIII. All of these in vivo sites
were also found in recombinant GST-BAK1-CD autophosphory-
lated in vitro (Table 1 and Wang et al., 2005b). Two additional
sites, S286 and T450, were detected in vitro but not in repeated
in vivo analyses of BL-treated tissue (Table 1).
Specific targets of transphosphorylation between BRI1 and
BAK1were also identified in vitro by pairing kinase-active and -in-
active recombinant proteins asdescribed in Figure 2A. Flag-BRI1-
CDtransphosphorylatedGST-BAK1(K317E)-CDonall of thesame
residues that were autophosphorylated by GST-BAK1-CD alone,
with the exception of S286 (Table 1). In contrast, GST-BAK1-CD
transphosphorylated Flag-BRI1(K911E)-CD on JM sites (S838,
T846, and S858) and CT sites (S1166 and T1180), but no phos-
phorylatedKDsiteswere detected. All of these residueswere pre-
viously identified as potential in vitro autophosphorylation sites of
BRI1-CD (Ohetal., 2000), andS838andS858werealsoverifiedas
in vivo sites in BL-treated tissue (Wang et al., 2005b).
Mutating Specific BAK1 Phosphorylation
Sites Alters Kinase Function
The functional significance of identified BAK1 phosphorylation
sites (Table 1) was assessed by site-directed mutagenesis of
specific Ser or Thr residues to Ala, to eliminate phosphorylation
at that site, or to Asp, which can mimic constitutive phosphory-
lation under certain circumstances. Biochemical function of
BAK1-CD was analyzed by autophosphorylation levels by using
both incorporation of phosphate from [g-32P]ATP and immuno-
bloting with a-pThr antibody. The activation-loop residue T455
is equivalent to T1049 in BRI1 and is highly conserved in over
100 LRR RLKs in Arabidopsis (Wang et al., 2005b). Like the
T1049A substitution in BRI1, BAK1 T455A mutants lost nearly
all kinase activity. Furthermore, T455D and T455E mutants,
rather than mimicking constitutive phosphorylation, also led to
loss of kinase function, suggesting that any change in this critical
residue is likely to disrupt activity. A T1049D substitution in BRI1
also resulted in loss of kinase activity (Figure S5, available
online), further supporting the view that D substitutions at this
conserved residue do not have phosphomimetic properties.
The effect of mutating the remaining activation-loop residues,
T446, T449, and T450, was more subtle. When examined by
a-pThr blots, T-to-A substitutions in these residues reduced
kinase activity compared to the wild-type kinase, whereas T-
to-D substitutions increased activity above T-to-A mutant levels,
but not to the level of the wild-type kinase. However, when
monitored by kinase assays with [g-32P]ATP, all of these substi-
tutions appeared to increase kinase activity above wild-type
levels. This apparent discrepancy can be explained by our previ-
ous observationswith recombinant BRI1-CD,which showed that
the expressed KD can autophosphorylate to a very high degree
within the bacteria during recombinant protein production,
allowing for less uptake of phosphate from [g-32P]ATP during
subsequent kinase assays in vitro (Wang et al., 2005b). The
high level of wild-type BAK1-KD autophosphorylation in bacte-
ria, as shown by the a-pThr blot (Figure 3A), resulted in reduced
autophosphorylation levels with [g-32P]ATP, whereas the low
level of bacterial autophosphorylation seen in T446, T449, and226 Developmental Cell 15, 220–235, August 12, 2008 ª2008 ElsevieT450 mutants allowed for greater uptake of phosphate from
[g-32P]ATP during subsequent assays. Those constructs that
had high autophosphorylation within bacteria also exhibited
reduced electrophoretic mobility and doublet-band formation.
In contrast to activation-loop residues, substitutions at S290 or
T312 had no observable effect on autophosphorylation when
compared to wild-type BAK1-CD, nor did S286A. Surprisingly,
the S286D substitution resulted in complete loss of kinase activ-
ity, similar to the K317E kinase-inactive mutant. If indeed S286D
mimics constitutive phosphorylation, it suggests that S286 is
a negative, phosphorylation-dependent regulatory site.
The effects of substitutions within Flag-BAK1-CD on phos-
phorylation of BR13 by Flag-BRI1-CD were also monitored
(Figure 3B). As with autophosphorylation, kinase activity of sub-
stitutions at S290 or T312, as well as S286A, appeared similar to
wild-type, and S286Dwas again equivalent to the K317E kinase-
inactive mutation. T455A also resulted in complete loss of kinase
activity, whereas T455D and T455E had slightly increased activ-
ity compared to T455A, but still much lower than wild-type.
T446A and T450A substitutions did not reduce kinase activity
compared to wild-type, whereas T449A was slightly lower. How-
ever, T-to-D substitutions at these activation-loop sites substan-
tially increased Flag-BRI1-CD phosphorylation of BR13. In every
case, Flag-BAK1-CD appeared to function by enhancing BRI1
function rather than by directly phosphorylating BR13, since
wild-type BAK1 alone, or any of its mutants, did not significantly
phosphorylate BR13.
Mutating Specific BAK1 Phosphorylation Sites Alters
BR and Flagellin Signaling
The bri1-5 mutant, a weak allele mutated in the extracellular
domain (Noguchi et al., 1999), can be partially rescued by over-
expression of wild-type BAK1, whereas overexpression of a
BAK1(K317E) kinase-inactive mutant leads to a dominant-nega-
tive effect with severe bri1-1 dwarf phenotypes (Li et al., 2002).
To monitor in planta function, BAK1-GFP constructs mutated
at six specific phosphorylation sites were overexpressed in
bri1-5, and phenotypes were monitored visually in multiple inde-
pendent T1 transgenic lines (Figure 4A). Any change in T455 af-
fected biological function and resulted in a dominant-negative
effect almost as severe as the K317Emutant, which is consistent
with in vitro autophosphorylation assays (Figure 3A). S286A mu-
tants partially rescued bri1-5, whereas S286D caused a severe
dominant-negative phenotype, which is also consistent with
in vitro kinase results. This effect was evident at transgenic pro-
tein levels that were nearly undetectable by immunoblot analysis
(Figure 4A), but it was not due to cosuppression of endogenous
BAK1 gene expression (Figure S6). Examination of several inde-
pendent transgenic lines at different growth stages indicated
that the severity of the S286D phenotype was in fact correlated
with levels of transgenic BAK1-GFP(S286D) (Figure S6).
Similar to the in vitro assays (Figure 3A), the biological effect of
mutating T446, T449, and T450 was less pronounced, although
T450A appeared consistently smaller than wild-type (Figure 4A).
To determine if changes in these three residues might lead to
subtle phenotypes, quantitative analyses of two BR-dependent
growth responses, total plant height and leaf shape, were con-
ducted on three independent T3 homozygous transgenic lines
for each mutation (Figure 4B). In each case, the extent ofr Inc.
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Molecular Mechanisms of the BRI1/BAK1 InteractionFigure 3. Effect of Mutating Specific BAK1 Phosphorylation Sites on Autophosphorylation and Stimulation of BRI1 Substrate Phos-
phorylation
(A) Site-directed mutagenesis of Flag-BAK1-CD was used to alter each identified site of in vivo and in vitro phosphorylation in BAK1. Equal amounts of recombi-
nant protein (Stained Gel) were incubated with [g-32P]ATP (Autoradiograph) to determine autophosphorylation levels. Equal amounts of purified recombinant
protein (a-Flag Blot) were also subjected to immunoblot analysis (a-pThr Blot).
(B) Equal protein amounts of wild-type or mutated Flag-BAK1-CD were incubated with [g-32P]ATP, BR13 peptide, and with or without equal amounts of
Flag-BRI1-CD. Error bars are SEM; n = 3.bri1-5 rescue for both characteristics was directly correlated
with the level of transgenic protein, and T446A and T449A both
rescued to the same extent as wild-type BAK1-GFP when highly
expressed. T450A lines were expressed at intermediate levels
and gave phenotypes intermediate between bri1-5 and BAK1-
GFP. However, comparison of T450A and T450D lines exhibiting
equivalent expression showed that T450D enhanced biological
function compared to T450A.
As another test of biological function, the ability to rescue the
bak1-4 bkk1-1 severe doublemutantwas examined in transgenic
constructs driven by the native BAK1 promoter (Figure 5A).
Double mutant seedlings die after 15–20 days of growth, andDevelopwild-type BAK1-Flag as well as S286A, S290A, T446A, T449A,
and T450A were able to rescue this seedling-lethal phenotype.
However, the kinase-inactive K317E mutation, as well as
S286D and T455A, was ineffective, confirming the critical role
of a fully active kinase in BAK1 signaling. The FLS2 peptide ligand
flg22 inhibits Arabidopsis Col-0 seedling growth at low concen-
trations (10 nM), and bak1 mutants show reduced sensitivity to
flg22 (Chinchilla et al., 2007). Figure 5B shows that the bak1-4
bkk1-1 double mutant (transformed with empty vector) is ex-
tremely dwarfed, and that wild-type BAK1::BAK1-Flag restores
growth and flg22 sensitivity to levels equal to or greater than
Col-0, as do the S286A, S290A, T446A, and T449A mutations.mental Cell 15, 220–235, August 12, 2008 ª2008 Elsevier Inc. 227
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Molecular Mechanisms of the BRI1/BAK1 InteractionFigure 4. Functional Analysis of BAK1 Phosphorylation Sites In Planta
(A) Overexpression of CaMV35S::BAK1-GFP in the weak BR-insensitive mutant bri1-5 leads to partial suppression of the bri1-5 phenotype, whereas the kinase-
inactive BAK1-GFP(K317E) produces a dominant-negative effect, confirming previous results (Li et al., 2002). Wild-type Arabidopsis (ecotype Ws-2) is shown for
comparison. The effect of mutating specific phosphorylation sites in CaMV35S::BAK1-GFP on the suppression of the bri1-5 phenotype is shown for three inde-
pendent T1 transgenic lines for each construct. The level of transgenic protein is shown by a-GFP immunoblot analysis of equal amounts of total protein extracted228 Developmental Cell 15, 220–235, August 12, 2008 ª2008 Elsevier Inc.
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Molecular Mechanisms of the BRI1/BAK1 InteractionThis indicates that phosphorylation at these residues is not
critical for BAK1 regulation of FLS2 function. However, a T450A
substitution restores growth while retaining complete flg22 in-
sensitivity, suggesting that phosphorylation at this residue may
specifically enhance BAK1 regulation of FLS2 signaling. The
kinase-inactive mutants K317E, S286D, and T455A were also
tested in the flg22 assay, but since these constructs failed to
rescue the seedling lethality of the bak1-4 bkk1-1 doublemutant,
not enough viable seedlings remained at day 18 for a statistically
significant analysis of growth response.
BAK1 Quantitatively Enhances BRI1 Phosphorylation
Levels and Kinase Function
Taken together, the results in Figures 1–3 and Table 1 are consis-
tent with a model in which BAK1 transphosphorylates BRI1 on
specific JM and CT residues, which then increases the ability
of BRI1 to phosphorylate its substrates. If this model is correct,
phosphomimetic mutants in which specific JM and CT S/T resi-
dues are replaced by D should reduce or eliminate the need for
BAK1 to increase BRI1 phosphorylation of the BR13 peptide
substrate. To test this model, JM and CT residues in BRI1 known
to be transphosphorylated by BAK1 (Table 1), plus additional
residues previously identified as BRI1 phosphorylation sites
(Wang et al., 2005b), were mutated. Figure 6A shows that a mu-
tant construct (CT5D) of Flag-BRI1-CD containing S1166D,
S1168D, S1172D, S1179D, and T1180D displays a substantial
BAK1-independent increase in activity and phosphorylates
BR13 in the absence of GST-BAK1-CD to the same level as
wild-type Flag-BRI1-CD in the presence of GST-BAK1-CD.
However, addition of BAK1 to CT5D increases BR13 phosphor-
ylation even further, suggesting that additional CT5D sites
(perhaps in the JM region) are being phosphorylated by BAK1
to enhance CT5D activity above that of wild-type BRI1 plus
BAK1. Similarly, JM4D, containing S838D, T842D, T846D, and
S858D in the JM region of Flag-BRI1-CD enhances kinase func-
tion significantly in the absence of BAK1 (Figure 6A). Addition of
BAK1 increases JM4D activity even further, again most likely by
additional phosphorylation of unmutated sites (perhaps in the CT
region). The combined construct (JMCT9D) again shows en-
hanced function without BAK1 and a response to added BAK1
that is less than either JM4D or CT5D. The slight response to
BAK1 addition suggests that other residues in JMCT9D are
phosphorylated in response to BAK1 either in the JM, CT, or
even the KD region. These may be real transphosphorylation
sites that went undetected in our LC/MS/MS analysis, or they
may be sites that are only phosphorylated significantly when
the primary sites of BAK1 transphosphorylation are mutated.
The BAK1 plus:BAK1 minus ratios for wild-type (2.4x) and
JMCT9D (1.2x) clearly show that phosphomimetic mutations
confer significant BAK1 independence on BRI1 with respect to
enhanced phosphorylation of BR13.
To further confirm that BAK1 quantitatively enhances BRI1
phosphorylation levels, we used an advanced label-free quanti-Develofication procedure for Q-ToF LC/MS/MS analysis termed
LC/MSE, which allows for accurate determination of phosphory-
lation levels at individual residues (Silva et al., 2006; Vissers
et al., 2007). Focusing on the BRI1 S1166 residue, which is
a site of BAK1 transphosphorylation (Table 1), we found that
the average percent phosphorylation of S1166 minus BAK1
was 40.1%, which increased significantly to 64.5% upon the ad-
dition of BAK1 (Figure 6B). Thus, BAK1 quantitatively enhances
BRI1 phosphorylation at a specific residue, although the contri-
bution of direct BAK1 transphosphorylation versus BAK1-stimu-
lated BRI1 autophosphorylation could not be determined in this
experiment.
Specific JM Mutations Quantitatively Affect BR
Signaling In Vivo
We previously demonstrated that eliminating phosphorylation at
specific BRI1 JM sites with the mutants S838A, T846A, and
S858A (the three JM sites in BRI1 shown here to be transphos-
phorylated by BAK1) resulted in BR13 peptide phosphorylation
at levels of only 12%–16% of that seen with wild-type BRI1-KD
(Wang et al., 2005b). Measurement of hypocotyl length in in-
creasing concentrations of the BR biosynthesis inhibitor Brz
has been successfully used to quantitatively assess the effect
of BRI1 mutations on BR signaling (Wang et al., 2005a). There-
fore, we used this system to determine if the S838A, T846A,
and S858A substitutions, would quantitatively affect BR signal-
ing in planta. As shown in Figure 6C, overexpressing wild-type
35S-BRI1-Flag in the bri1-5mutant resulted in hypocotyl lengths
greater than untransformed wild-type Arabidopsis. However, in
independent transgenic lines showing approximately equal
transgenic protein levels, S838A, T846A, and S858A all exhibited
a quantitative reduction in BR signaling output, as shown by hy-
pocotyl lengths intermediate between wild-type BRI1-Flag and
the untransformed bri1-5mutant (Figure 6C). The only exception,
line 1 of T846A, had much higher levels of transgenic protein,
which confirms the correlation of phenotype with levels of trans-
genic protein. Thus, altering specific BRI1 residues that are the
target of BAK1 transphosphorylation quantitatively affects BR
signaling in planta and BRI1 kinase function in vitro.
DISCUSSION
The ligand-dependent association of BRI1 with BAK1 and other
members of the SERK family of LRR RLKs supports the hypoth-
esis that BR signaling shares some mechanistic similarities to
mammalian RTK and TGF-b receptor kinase signaling. In order
to investigate the detailed mechanism of BRI1/BAK1 interaction
and determine the extent of conservation with mammalian
receptor kinase modes of action, we used transgenic plants ex-
pressing epitope-tagged BRI1 and BAK1 (either native proteins
or kinase-inactive mutants) in different genetic backgrounds to
study BR dependence of the physical association of the pair
and the ability to auto- and transphosphorylate in the complex.from plants of the same age. All plants were grown under the same conditions for 39 days before photographing. Even very low levels of S286D expression led to
dominant-negative effects, which were not the result of cosupression of endogenous BAK1, BKK1, or BRI1 (Figure S5).
(B) Total plant height and leaf shape, two BR-dependent morphological characteristics, are partially rescued by overexpression of CaMV35S::BAK1-GFP in bri1-
5. The effects of mutating the activation-loop residues T446, T449, and T450 on this rescue were examined in three independent T3 homozygous transgenic lines
expressing varying levels of transgenic protein (determined by a-GFP immunoblot analysis). Measurements were taken at 64 days. Error bars are SEM; n = 7.pmental Cell 15, 220–235, August 12, 2008 ª2008 Elsevier Inc. 229
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Molecular Mechanisms of the BRI1/BAK1 InteractionFigure 5. Effect of Mutating Specific Phosphorylation Sites of BAK1 on the Rescue of the Severe bak1-4 bkk1-1 Double Mutant
(A) Expression of BAK1::BAK1-Flag in bak1-1 bkk1-1 rescued the seedling-lethal phenotype of the double mutant. Kinase-inactive forms of BAK1, including
K317E, S286D, and T455A, failed to rescue bak1-1 bkk1-1, and plants died after 20–25 days of growth (white arrows). Three independent T2 transgenic lines
for each construct are shown, and the level of transgenic protein was determined by a-Flag immunoblot analysis of equal amounts of total protein extracted
from plants of the same age. All plants were grown under the same conditions for 36 days before photographing.
(B) BAK1 T450 is a critical residue for flg22 sensitivity. Seedlings were grown on agar plates ± 10.0 nM flg22 peptide (QRLSTGSRINSAKDDAAGLQIA) for 18 days.
Independent T2 transgenic lines are the same as in (A) and are presented in the same order (left to right). The aerial portion of each seedling was weighed indi-
vidually. Error bars are SEM; n = 10.Our LC/MS/MS analysis identified individual phosphorylation
sites in BRI1 and BAK1, and functional analysis of these sites
both in planta and in vitro helped to define the specific role of
BRI1 and BAK1 kinase function in the interaction of these LRR
RLKs. The data presented here are consistent with a sequential
transphosphorylation mechanism of BR signaling in which BRI1230 Developmental Cell 15, 220–235, August 12, 2008 ª2008 Elsevcan act independently from BAK1 (and its homolog BKK1) with
respect to ligand binding, initial kinase activation, and participa-
tion in a basal level of BR signaling in hypocotyl elongation, a typ-
ical BR-promoted growth response. However, the full potential
of BR signaling is realized when ligand-activated BRI1 interacts
directly with BAK1, leading to BAK1 kinase activation byier Inc.
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Molecular Mechanisms of the BRI1/BAK1 InteractionFigure 6. BRI1 Residues that Are Targets of BAK1 Transphosphorylation Quantitatively Affect BRI1 Kinase Activity and BR Signaling Output
(A) Incubation of equal protein amounts (1.0 mM) of GST-BAK1-CDwith [g-32P]ATP and several Flag-BRI1-CD constructs shows that phoshomimeticmutants can
substitute for BAK1 in enhancing BRI1 phosphorylation of the BR13 peptide substrate. JM4D = S838D, T842D, T846D, S858D; CT5D = S1166D, S1168D,
S1172D, S1179D, T1180D; JMCT9D = JM4D + CT5D. Error bars are SEM; n = 3.
(B) Three independent LC/MSE experiments show that incubation of BRI1 with BAK1 quantitatively increases the level of phosphorylation at the BRI1 CT residue
S1166. A Student’s t test showed that the difference in mean percent phosphorylation between BAK1 plus and BAK1 minus was significant (p value of 0.06).
(C) Hypocotyl length was measured in 7-day-old seedlings (3 days total darkness followed by 4 days in 16 hr light:8 hr dark) for three independent T2 transgenic
lines plus controls. Transgenic protein levels were determined by a-Flag immunoblot. Error bars are SEM; n = 10.BRI1-mediated transphosphorylation of BAK1 activation-loop
residues. The activated BAK1, in turn, transphosphorylates
BRI1 on JM and CT residues, quantitatively increasing BR sig-
naling by enhancing the phosphorylation of specific BRI1
substrates (Figure 7).
This model has several similarities with, but also distinct differ-
ences from, mammalian receptor kinase function. Members of
the TGF-b family of peptides modulate numerous aspects of
mammalian development and are perceived at the cell surface
by a complex of Type II (RII) and Type I (RI) receptor serine/thre-
onine kinases. TGF-b-RII receptors homodimerize in the ab-
sence of ligand, and TGF-b binding by RII homodimers induces
the formation of a heterotetramer with TGF-b-RI, resulting inDevelophosphorylation of RI by RII on specific Thr and Ser residues in
the JM domain (Massague, 1998; Rahimi and Leof, 2007).
Although it has a ligand-binding domain, TGF-b-RI cannot bind
ligand in the absence of TGF-b-RII, but it does so cooperatively
in the presence of the TGF-b-RII ligand complex to generate the
active heterotetramer. In contrast, RI receptors in the related
bonemorphogenetic protein family do bind ligand independently
of RII and exhibit a different mechanism of heterotetramer
assembly (Massague, 2008). BRI1 appears to be analogous to
TGF-b-RII, in that it homodimerizes in the absence of ligand
(Russinova et al., 2004; Wang et al., 2005a; Hink et al., 2008)
and binds BL in the absence of its coreceptor BAK1 (Kinoshita
et al., 2005), whereas BAK1 is similar to TGF-b-RI, in that itpmental Cell 15, 220–235, August 12, 2008 ª2008 Elsevier Inc. 231
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Molecular Mechanisms of the BRI1/BAK1 InteractionFigure 7. The Sequential Transphosphory-
lation Model of BRI1/BAK1 Interaction and
Activation
BL binds inactive BRI1 homodimers, resulting in
kinase activation and release of the BKI1 (Wang
and Chory, 2006) negative regulator. BRI1, acti-
vated by BL binding and transphosphorylation in
the homodimer (double arrows), can signal
independently of BAK1 to promote plant growth
or oligomerize with inactive BAK1 and transphos-
phorylate it on KD residues. This BRI1-activated
BAK1 then transphosphorylates BRI1 on JM and
CT residues, thus quantitatively enhancing BRI1
phosphorylation of downstream substrates and in-
creasing BL-dependent signaling. Ourmodel does
not rule out the possibility that BAK1 also trans-
phorylates BRI1 on KD residues that were below
the level of detection in our LC/MS/MS analyses.
Only BL signaling is shown; the known interaction
of BAK1 with BL-independent signaling compo-
nents such as the FLS2 receptor kinase is omitted
from this model for simplicity. The question mark
represents the possibility that BAK1 may have as
yet undiscovered cytoplasmic substrates in addi-
tion to the BRI1 CD. BKK1 and SERK1 (not shown)
may substitute for BAK1 in these complexes.cannot independently bind ligand but requires ligand-dependent
activation of its partner before formation of a putative heterote-
tramer can proceed. However, BAK1 differs from TGF-b-RI in
that BAK1 does not possess a BR-binding site, and thus coop-
erative binding with the BRI1-BR complex may not be critical
for BRI1/BAK1 complex formation (Kinoshita et al., 2005). Our
data indicate that a key feature in BRI1/BAK1 complex formation
is an active BRI1 kinase, which could be directly involved in bind-
ing or might function through release of the BKI1 repressor
(Wang and Chory, 2006). Although BRI1 and BAK1 may form
a simple heterodimer, recent data (Wang et al., 2005a; Karlova
et al., 2006) tend to support a heterotetrameric model as shown
in Figure 7.
Our in vivo data clearly show that BL-dependent phosphoryla-
tion of BAK1 on Thr residues requires an active BRI1 kinase, and
thus the initial direction of phosphorylation is fromBRI1 to BAK1,
similar to the RII-to-RI transphosphorylation in TGF-b signaling.
However, in contrast to the RII/RI heterotetramer, our in vitro
data suggest that BAK1 is phosphorylated by BRI1 in the KD,
including three residues in the activation loop, rather than the
JM region, and these sites were verified as in planta phosphory-
lation sites for BAK1. Moreover, BAK1 autophosphorylates the
same sites in vitro in the absence of BRI1. However, the ex-
tremely low level of BAK1-GFP phosphorylation in vivo in the
bri1-1 null mutant background suggests that initial activation
by BRI1 phosphorylation is required for BAK1 to function in BL
signaling, which then may be further amplified by BAK1 auto-
phosphorylation on the same residues. Our data cannot rule
out the possibility that JM or CT residues are phosphorylated
in BAK1 at levels below detection by our LC/MS/MS analysis,
but the predominant phosphorylation on BAK1 residues in the
KD represents a clear difference between BR and TGF-bmecha-
nisms. Interestingly, phosphorylation of the activation-loop resi-
due T455 appears to be essential for BAK1 function, and we pre-
viously found that the corresponding BRI1 residue T1049 was232 Developmental Cell 15, 220–235, August 12, 2008 ª2008 Elsevialso required for kinase function and BR signaling in planta
(Wang et al., 2005b). A Ser or Thr residue is conserved in this po-
sition in over 100 Arabidopsis LRR RLKs and thus may represent
a fundamental site for kinase activation in these proteins.
Once activated by phosphorylation, RI propagates the TGF-
b signal by phosphorylating proteins, termed Smads, which
translocate to the nucleus and form complexeswith transcription
factors to regulate the expression of TGF-b-responsive genes
(Massague, 1998; Rahimi and Leof, 2007). Although we cannot
rule out that BAK1 may have as yet undiscovered substrates
that propagate the BR signal downstream, our in vitro and
in vivo data clearly show that BAK1 can transphosphorylate
BRI1, and that elimination of BAK1 kinase function reduces
BRI1 phosphorylation levels in planta, which is distinctly different
from the primarily sequential direction of phosphorylation from
RII to RI in TGF-b signaling. Our data are consistent with previous
demonstrations of BRI1/BAK1 transphosphorylation (Li et al.,
2002; Nam and Li, 2002) but extend these findings by clarifying
the directional flow of phosophorylation between BRI1 and
BAK1 in planta and by identifying individual sites of transphos-
phorylation in each LRR RLK. Although there may be KD sites
of low stoichiometry not detected in our LC/MS/MS analysis,
the predominant sites of BRI1 phosphorylation by BAK1 are
clearly JM and CT residues that we previously showed were es-
sential for BRI1 phosphorylation of an optimal peptide substrate
(Wang et al., 2005b).
Based on our in vitro kinase assays, transphosphorylation of
these BRI1 JM and CT residues by BAK1 stimulates BRI1 kinase
function and increases its activity toward downstream sub-
strates. Moreover, phosphomimetic mutants in which these spe-
cific residues are changed to D show significantly enhanced
BRI1 activity and peptide substrate phosphorylation in the
absence of BAK1 in vitro. A focused LC/MS/MS analysis of a
selected BRI1 site (S1166) confirms that BAK1 association
increases the level of BRI1 phosphorylation at that residue.er Inc.
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dues by substitution with A quantitatively reduces BR signaling
output in vivo. Thus, all of our data are consistent with a model
in which BAK1 quantitatively enhances BRI1 function by trans-
phosphorylation of specific BRI1 residues that are essential for
kinase function. The in planta confirmation of this aspect of our
model is hampered by the lack of demonstrated BRI1 in vivo
substrates. Besides BAK1, three other proteins have been
shown to interact with BRI1 in vivo and be phosphorylated by
BRI1-KD in vitro (Nam and Li, 2004; Ehsan et al., 2005; Wang
and Chory, 2006), but in vivo phosphorylation of these proteins
by BRI1 is not confirmed and thus the role of BAK1 in enhancing
phosphorylation of these proteins via BRI1 cannot be examined.
The transphosphorylation of BRI1 and BAK1 within the associ-
ated complex in some aspects more closely resembles mamma-
lianRTKmechanisms than theTGF-bmodel. Ligandbinding to the
extracellular domain of RTKs induces dimerization, which acti-
vates theKDof eachmemberof thepair either byphosphorylation
or allosteric conformational change of the activation loop. The ac-
tivatedkinaseswithin thedimer transphoshorylateonTyr residues
in the CT region to generate docking sites for downstream signal-
ing proteins (Schlessinger, 2002). The apparent phosphorylation
of BRI1, but not BAK1, on CT residuesmay represent a modifica-
tionof the transphosphorylationmechanisms forBRsignalingver-
susmammalianRTKs. Thebest understoodRTKsmechanistically
aremembersof theepidermalgrowth factor (EGF) receptor family,
which includes four members, ErbB1 through ErbB4. ErbB2 can-
not itself bind EGF ligand, but it heterodimerizes with the other
threemembersof the family in a ligand-dependentmanner, signif-
icantly enhancing the signaling output of each (Hubbard and
Miller, 2007). In this respect, ErbB2 resembles BAK1, in that it
does not determine signaling specificity by directly binding a li-
gand, but instead enhances activity of its ligand-binding partner.
BAK1 has nowbeen shown to associatewith other LRRRLKpart-
ners besides BRI1, including FLS2 (Chinchilla et al., 2007; Heese
et al., 2007), and differential BAK1 phosphorylation may be in-
volved in its participation in distinct signaling pathways, including
BR-promoted growth, regulation of cell death, and defense re-
sponses to pathogens. For example, our data show that the
T450A mutation in BAK1 does not suppress the bri1-5mutant to
the extent that S290A, T446A, and T449A mutations do, but it
does fully rescue the BR-independent growth defects of the
bak1 bkk1 double mutant, suggesting that phosphorylation at
T450 may be important in BR signaling, but not the enhanced
cell death phenotype observed in the bak1 bkk1 mutant (He
et al., 2007). In our LC/MS/MS analysis of in vivo BAK1 phosphor-
ylation sites, the b and y ions generated from the detected phos-
phopeptides suggest that pT449 was the modified residue,
although pT450 could not be unequivocally excluded. Thus, BL-
induced phosphorylation of T450 in vivo cannot be ruled out and
in fact is supported by the transphosphorylation of BAK1 T450
by BRI1-CD in vitro. The highly specific loss of flagellin sensitivity
in the T450A mutant observed here, is also quite striking and
suggests that phosphorylationofBAK1T450maybecrucial for in-
teraction with and activation of FLS2. A quantitative comparative
analysis of BAK1 in vivo phosphorylation sites in BL versus flagel-
lin-treated tissue would be informative in this respect.
Finally, the extreme kinase-inactive phenotype of BAK1
S286D mutants suggests that phosphorylation at this residueDevelopmight be a negative regulator of BAK1 function in a specific
signaling pathway. Phosphorylation at S286 was not detected
in BL-treated tissue in repeated experiments, and it was not a
site of in vitro transphosphorylation of BAK1-CD by BRI1-CD.
Therefore, if S286 is indeed phosphorylated in vivo, it may be in
response to a non-BL ligand in partnership with an undiscovered
LRR RLK.
The very large number of LRRRLKs found inArabidopsis pres-
ent immense possibilities for heterodimerization or oligomeriza-
tion and thus the diversification and amplification of signaling
pathways regulating plant growth and development. Our analy-
sis of the BRI1/BAK1 interaction helps clarify early events of
BR signaling and serves as a foundation for analysis of other
LRR RLKs to determine if a sequential transphosphorylation
mechanism exists in other heteromeric complexes. To this
end, we have cloned the entire LRR RLK family in a variety of
plant and bacterial expression vectors to aid in studies of kinase
function, phosphorylation-site analysis, and protein-protein in-
teractions (Clouse et al., 2008). Such global studies should
help to reveal whether sequential transphosphorylation, as ob-
served here in BRI1/BAK1 interactions, is a general mechanism
of plant receptor kinase action.
EXPERIMENTAL PROCEDURES
Plant Growth, Transgenic Lines, and Protein Analysis
Plants were grown in shaking liquid culture or growth chambers and were
treated with 100 nM BL or 2.0 mM Brz 220 as previously described (Wang
et al., 2005b). Transgenic lines BRI1-Flag, BAK1-GFP, mBRI1-Flag (K911E),
and mBAK1-GFP (K317E) are described elsewhere (Li et al., 2002). Details
of cloning, in vitro mutagenesis, and plant transformation for other lines
used are provided in the Supplemental Data. Total membrane protein isolation,
immunoprecipitation, and immunoblot analysis were performed as previously
described (Wang et al., 2005b).
Recombinant Protein Production and In Vitro Kinase Assays
Generation of Flag-BRI1-CD and Flag-mBRI1-CD is described elsewhere (Oh
et al., 2000). Construction of GST-BAK1-CD, Flag-BAK1-CD, and associated
site-directed mutants is described in detail in the Supplemental Data. Purifica-
tion of recombinant protein and general conditions for kinase autophosphory-
lation and peptide substrate assays are as previously described (Oh et al.,
2000; Wang et al., 2005b); details for specific experiments are provided in
the Supplemental Data.
Determination of In Vivo and In Vitro Phosphorylation
Sites by LC/MS/MS
For in vivo and in vitro phosphorylation-site analysis, BAK1-GFP was immuno-
precipitated from solubilized total membrane protein extracts isolated from
Arabidopsis plants treated with 100 nM BL, and recombinant GST-BAK1-CD
and Flag-BRI1-CD were expressed and purified as previously reported
(Wang et al., 2005b), withminormodifications that are described in the Supple-
mental Data. Microcapillary reversed-phase ion trap LC/MS/MS analysis of
peptide samples was performed in a data-dependent MS/MS mode with an
Agilent 1100capillary LCsystem (Agilent Technologies, Inc., PaloAlto,CA) cou-
pled to a LCQ Deca ion trap mass spectrometer (Thermo Finnigan, San Jose,
CA), by using previously described conditions (Wang et al., 2005b). For Quad-
rupole Time-of-Flight (Q-ToF) LC/MS/MS, aliquots of in-gel digests were sub-
jected to data-dependent analysis by using a NanoAcquity UPLC coupled to
a Premier Q-ToF mass spectrometer equipped with a nanolockspray source
(Waters Corporation,Milford,MA). Label-free quantitative analysis of the phos-
phorylation levels of BRI1 S1166was performed on thePremier Q-ToF by using
the LC/MSE procedure and algorithms (Silva et al., 2006; Vissers et al., 2007).
Further details of sample preparation, LC/MS/MS analysis, and search
algorithm parameters are provided in the Supplemental Data.mental Cell 15, 220–235, August 12, 2008 ª2008 Elsevier Inc. 233
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Supplemental Data include detailed Supplemental Experimental Procedures,
six figures, and Supplemental References and can be found at http://www.
developmentalcell.com/cgi/content/full/15/2/220/DC1/.
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